Company: PSTV
Filing Date: 2025-05-30
Form Type: 10-Q
Source: 0000950170-25-079738
Chunk: 0

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-05-30
Form: 10-Q
Item: Item 1
Chunk 0
---
PLUS THERAPEUTICS, INC. 

 CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(in thousands, except share and par value data)

     March 31, 2025

     December 31, 2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     9,867

     $
     76

     Investments

     —

     3,530

     Grant receivable

     —

     571

     Other current assets

     1,001

     1,082

     Total current assets

     10,868

     5,259

     Property and equipment, net

     324

     448

     Operating lease right-use-of assets

     38

     73

     Goodwill

     372

     372

     Intangible assets, net

     435

     469

     Other assets

     19

     12

     Total assets
      
     $
     12,056

     $
     6,633

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable and accrued expenses
      
     $
     9,222

     $
     11,288

     Operating lease liability

     40

     44

     Deferred grant liability

     1,297

     927

     Line of credit

     —

     3,292

     Total current liabilities

     10,559

     15,551

     Warrant liability

     25,138

     —

     Noncurrent operating lease liability

     —

     31

     Total liabilities

     35,697

     15,582

     Commitments and contingencies (Note 7)

     Stockholders’ equity (deficit):

     Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,952 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively

     —

     —

     Common stock, $0.001 par value; 100,000,000 shares authorized; 17,258,051 and 16,999,626 issued and outstanding at March 31, 2025, and 6,154,758 issued and 5,896,333 outstanding